Visfatin and Subclinical Atherosclerosis in Type 2 Diabetes: Impact of Cardiovascular Drugs

Visfatin and Subclinical Atherosclerosis in Type 2 Diabetes: Impact of Cardiovascular Drugs

<i>Background and Objectives</i>: The role of adipokines in the development of atherosclerosis in type 2 diabetes (T2DM) has not yet been fully elucidated. The effects of drugs on adipokine concentrations have only been evaluated in very few studies, although they may be of clinical impo...

Full description

Bibliographic Details
Main Authors:	Kati Kärberg, Alastair Forbes, Margus Lember
Format:	Article
Language:	English
Published:	MDPI AG 2023-07-01
Series:	Medicina
Subjects:	adipokines atherosclerosis type 2 diabetes mellitus intima–media thickness ankle–brachial index cardiovascular drugs
Online Access:	https://www.mdpi.com/1648-9144/59/7/1324

Similar Items

Unlocking the Dietary Puzzle: How Macronutrient Intake Shapes the Relationship between Visfatin and Atherosclerosis in Type 2 Diabetes
by: Kati Kärberg, et al.
Published: (2024-03-01)

Subclinical Atherosclerosis, Vascular Risk Factors, and White Matter Alterations in Diffusion Tensor Imaging Findings of Older Adults With Cardiometabolic Diseases
by: Yoshiaki Tamura, et al.
Published: (2021-08-01)

Subclinical Atherosclerosis in Patients with Cushing Syndrome: Evaluation with Carotid Intima-Media Thickness and Ankle-Brachial Index
by: Luigi Petramala, et al.
Published: (2015-12-01)

Secondhand Smoke Exposure and Subclinical Cardiovascular Disease: The Multi‐Ethnic Study of Atherosclerosis
by: Miranda R. Jones, et al.
Published: (2016-12-01)

Using Mathematical and Statistical Analysis to Investigate the Correlation between Exacerbation of Chronic Obstructive Pulmonary Disease and Risk of Subclinical Atherosclerosis
by: Xiaochun Dai, et al.
Published: (2023-02-01)

Value of the arterial stiffness index and ankle brachial index in subclinical atherosclerosis screening in healthy community-dwelling individuals
by: Javad Alizargar, et al.
Published: (2019-01-01)

Comparison of diagnostic utilities of ankle–brachial index and Carotid intima-media thickness as surrogate markers of significant coronary atherosclerosis in Indians
by: Babu Ezhumalai, et al.
Published: (2013-03-01)

The significance of detection of preclinical atherosclerosis
by: Pavel Poredoš, et al.
Published: (2006-08-01)

Research progress of improving subclinical atherosclerosis with exercise
by: RUAN Weiqi, et al.
Published: (2023-02-01)

Evaluation of Ankle-Brachial Pressure Index and Carotid Intima Media Thickness by Doppler Ultrasound in type two Diabetics.
by: Wijdan F. AL-Siaidy, et al.
Published: (2013-04-01)

Markers of subclinical atherosclerosis in the ten-year risk estimation of cardiovascular events
by: P. V Bovtyushko, et al.
Published: (2015-12-01)

Association between nonalcoholic fatty liver disease and subclinical atherosclerosis: a cross-sectional study on population over 40 years old
by: Jilin Zheng, et al.
Published: (2018-07-01)

Premature Parental Cardiovascular Disease and Subclinical Disease Burden in the Offspring
by: Wolfgang Lieb, et al.
Published: (2020-09-01)

Utility of ankle–brachial pressure index/carotid intima-media thickness ratio in predicting presence and severity of coronary artery disease: A study from major center in Northeastern India
by: Farhin Iqbal, et al.
Published: (2019-01-01)

Evaluation of subclinical atherosclerosis in chronic sinusitis patients
by: Musa Çakıcı, et al.
Published: (2015-04-01)

Carotid intima-media thickness as an indicator of subclinical atherosclerosis in systemic lupus erythematosus patients
by: Asmaa A Abozeid, et al.
Published: (2021-01-01)

Carotid intima-media thickness as a biomarker of subclinical atherosclerosis
by: Marcus Bauer, et al.
Published: (2012-10-01)

The Value of Subclinical Carotid Atherosclerosis for Primary Prevention of Cardiovascular Diseases. Review of the Main International Studies
by: E. K. Butina, et al.
Published: (2016-11-01)

The Relationship between Abnormal Ankle-brachial Index and Micro-vascular Complications of Diabetes Type II
by: Mohammad Hossein Gozashti, et al.
Published: (2020-09-01)

Could SCUBE-1 be a marker for subclinical atherosclerosis other than carotid artery intima-media thickness in patients with psoriasis?
by: Havva Hilal Ayvaz Çelik, et al.
Published: (2023-08-01)

The Association Between Insomnia and Atherosclerosis: A Brief Report
by: Pan XL, et al.
Published: (2022-03-01)

Atherosclerosis in patients with endometriosis
by: Amir Hassan Habibi, et al.
Published: (2019-05-01)

Tofogliflozin long-term effects on atherosclerosis progression and major clinical parameters in patients with type 2 diabetes mellitus lacking a history of cardiovascular disease: a 2-year extension study of the UTOPIA trial
by: Naoto Katakami, et al.
Published: (2023-06-01)

Relation of glycated hemoglobin with carotid atherosclerosis in ischemic stroke patients: An observational study in Indian population
by: Amit Shankar Singh, et al.
Published: (2013-01-01)

Assessment of plasma ceramides as predictor for subclinical atherosclerosis
by: Pashupati P. Mishra, et al.
Published: (2021-11-01)

Evaluation of arterial stiffness and subclinical atherosclerosis in patients with Behçet's disease without cardiovascular involvement
by: Alp Yıldırım, et al.
Published: (2016-10-01)

Subclinical Carotid Atherosclerosis in Patients with Rheumatoid Arthritis at Low Cardiovascular Risk
by: Elena V. Gerasimova, et al.
Published: (2023-03-01)

The Usefulness of High-Resolution Carotid Ultrasonography for the Detection of Subclinical Atherosclerosis
by: Neskubina OM, et al.
Published: (2015-10-01)

Assessment of subclinical atherosclerosis in ankylosing spondylitis: correlations with disease activity indices
by: F.M. Perrotta, et al.
Published: (2013-07-01)

Age, gender and hypertension as major risk factors in development of subclinical atherosclerosis
by: Ajla Rahimić Ćatić, et al.
Published: (2013-04-01)

Age, gender and hypertension as major risk factors in development of subclinical atherosclerosis
by: Ajla Rahimić Ćatić, et al.
Published: (2013-04-01)

Serum irisin and apelin levels and markers of atherosclerosis in patients with subclinical hypothyroidism
by: Hamiyet Yilmaz Yasar, et al.

Are Non-Invasive Modalities for the Assessment of Atherosclerosis Useful for Heart Failure Predictions?
by: Kazuhiro Osawa, et al.
Published: (2023-01-01)

Comparison of intima-media thickness and ophthalmic artery resistance index for assessing subclinical atherosclerosis in HIV-1-infected patients
by: Tana Mariangela, et al.
Published: (2011-04-01)

Variability of intima-media thickness of the common carotid arteries in Moscow city population without clinical symptoms of atherosclerosis
by: Igor' Aleksandrovich Sobenin, et al.
Published: (2011-12-01)

Association between microalbuminuria and subclinical atherosclerosis evaluated by carotid artery intima-media in elderly patients with normal renal function
by: Kong XiangLei, et al.
Published: (2012-06-01)

Cruciferous and Total Vegetable Intakes Are Inversely Associated With Subclinical Atherosclerosis in Older Adult Women
by: Lauren C. Blekkenhorst, et al.
Published: (2018-04-01)

Early Pregnancy Cardiovascular Health and Subclinical Atherosclerosis
by: Laura Benschop, et al.
Published: (2019-08-01)

Correlation between Glycated Hemoglobin, Extra-cranial Carotid Artery Disease and Peripheral Arterial Disease in Type 2 Diabetic Patients with Coronary Artery Disease
by: Mohammed Darwish, et al.
Published: (2022-09-01)

Relationship between retinopathy and asymptomatic atherosclerosis determined by measurement of carotid intima-media thickness in patients with type 2 diabetes mellitus
by: İbrahim Kocaoğlu, et al.
Published: (2016-02-01)